Mikafungin Teva (Micafungin)

Micafungin, the active ingredient in Mikafungin Teva, is an echinocandin antifungal presented as an intravenous solution for intravenous use. It treats invasive fungal infections such as candidemia, esophageal candidiasis, and is used for prophylaxis in hematopoietic stem cell transplantation patients.

GNH USA supplies Mikafungin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Mikafungin Teva is an echinocandin antifungal indicated for several serious fungal infections.

- Invasive candidiasis: treatment of systemic Candida infection in immunocompromised patients. - Esophageal candidiasis: eradication of Candida infection of the esophagus. - Candidemia: clearance of Candida species from the bloodstream. - Prophylaxis of fungal infections in hematopoietic stem cell transplantation: prevention of invasive fungal disease in transplant recipients.

Mikafungin Teva may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Fever: transient temperature rise during infusion. - Nausea: mild gastrointestinal upset. - Elevated liver enzymes: transient increase in ALT/AST. - Infusion‑related reactions: flushing, rash, or mild hypotension.

Serious or Rare Side Effects: - Hepatic failure: severe liver injury requiring monitoring. - Severe hypersensitivity: anaphylactic reactions that may be life‑threatening. - Renal dysfunction: acute kidney injury in susceptible patients.

Before initiating therapy, clinicians should consider several safety measures.

- Liver function monitoring: check ALT/AST before and during treatment. - Renal function assessment: evaluate creatinine clearance prior to use. - Hypersensitivity screening: discontinue if signs of allergic reaction appear. - Drug interaction review: assess concomitant medications that may affect micafungin metabolism. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Cyclosporine: increased micafungin exposure may require dose adjustment. - Rifampin: decreased micafungin levels can reduce antifungal effectiveness.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): potential additive hepatotoxicity. - Warfarin: possible alteration of INR; monitor coagulation parameters. - Statins (e.g., simvastatin): increased risk of myopathy; monitor creatine kinase levels.